Research / 2018 / Article

Research Article | Open Access

Volume 2018 |Article ID 3917986 |

S. Bathini, D. Raju, S. Badilescu, A. Kumar, R. J. Ouellette, A. Ghosh, M. Packirisamy, "Nano–Bio Interactions of Extracellular Vesicles with Gold Nanoislands for Early Cancer Diagnosis", Research, vol. 2018, Article ID 3917986, 10 pages, 2018.

Nano–Bio Interactions of Extracellular Vesicles with Gold Nanoislands for Early Cancer Diagnosis

Received23 May 2018
Accepted19 Sep 2018
Published09 Oct 2018


Extracellular vesicles or exosomes are membrane encapsulated biological nanometric particles secreted virtually by all types of cells throughout the animal kingdom. They carry a cargo of active molecules to proximal and distal cells of the body as mechanism of physiological communication, to maintain natural homeostasis as well as pathological responses. Exosomes carry a tremendous potential for liquid biopsy and therapeutic applications. Thus, there is a global demand for simple and robust exosome isolation methods amenable to point-of-care diagnosis and quality control of therapeutic exosome manufacturing. This can be achieved by molecular profiling of the exosomes for use with specific sets of molecular-markers for diagnosis and quality control. Liquid biopsy is undoubtedly the most promising diagnosis process to advance “personalized medicine.” Currently, liquid biopsy is based on circulating cancer cells, cell free-DNA, or exosomes. Exosomes potentially provide promise for early-stage diagnostic possibility; in order to facilitate superior diagnosis and isolation of exosomes, a novel platform is developed to detect and capture them, based on localized surface plasmon resonance (LSPR) of gold nanoislands, through strong affinity between exosomes and peptide called Venceremin or Vn96. Physical modeling, based on the characteristics of the gold nanoislands and the bioentities involved in the sensing, is also developed to determine the detection capability of the platform, which is optimized experimentally at each stage. Preliminary results and modeling present a relationship between the plasmonic shift and the concentration of exosomes and, essentially, indicate possibilities for label-free early diagnosis.

1. Introduction

Exosomes or extracellular vesicles are vital sources of biomarkers for cancer and other pathological conditions such as inflammatory and neurodegenerative diseases and also for clinical diagnostics. They are membrane bounded nanoscale extracellular communication organelles that are released from almost all cell types to the extracellular space, transporting a cargo of active molecules (DNA, RNA, proteins/enzymes, lipid, and metabolites) to neighboring and distal parts of the body and represent real-time snapshots of the physiological/pathological status of the source cells. They are present in all body fluids, including urine, blood, ascites, and cerebrospinal fluid, and semen. When cells are cultured in laboratory or bioreactor settings, the cells discharge their exosomes in the culture-media used, called conditioned media. Exosomes are mostly spherical and their diameter ranges from 30 to 100 nm, which is about hundred times smaller than the smallest cell [16]. Exosomes are formed by inward budding of luminal membrane of multivesicular bodies and are constitutively released by fusion with the cytoplasmic membrane. Amongst the active molecules in the cargo, heat shock proteins (such as HSP70) are shown to be exosome membrane bound as well as inside [713]. It is evident in many cancers (for example, breast and ovarian) that the concentrations of the total cancer-cells and their exosome-bound HSPs are elevated [14] and implicated in various aspects of cancer biology.

The detection, isolation, and characterization of exosomes are still challenging due to the natural complexity of body fluids. For this reason, a versatile platform and an easy-to-use technique are required to adequately and selectively detect, isolate, quantify, and characterize exosomes for clinical applications. Given the growing evidence that exosomes may be the best liquid biopsy source materials for biomarker identification and discovery, there is a great demand for their simple, robust, and efficient isolation/detection from biofluids. However, currently available exosome isolation methods are precipitation based (ultracentrifugation and using polyethylene glycol) which are not suitable for point-of-care (POC) clinical-diagnosis. Ultrafiltration yields relatively pure exosomes but is technically challenging. For the development of routine exosome-based POC diagnostics, affinity-based exosome capture is technologically desirable. Most affinity-based exosome capture methods rely on monoclonal antibodies, directed against exosomes surface markers [1518], driving higher the cost of production and inconsistency in assays such as batch-to-batch variations of antibodies. Antibody-based affinity-capture and all the other precipitation-based exosome isolation facilitate capturing all the exosomes present in the given fluid, without differentiating healthy and diseased (cancer) exosomes. Quite sophisticated micro- and nanosystems have gained attention in recent years for their high sensitivity to detect exosomes. Among them are the electrochemistry-based approaches, using electroactive molecules tagged with a detection antibody and the captured exosomes are detected by electrochemical sensing [1921]. Nanoplasmonic sensors and microfluidic exosome analysis platforms having an antibody functionalized channel have also been reported [22, 23]. In spite of the advances in the exosome detection techniques, because of the complexity and heterogeneity of exosomes’ composition, none of the existing techniques can be considered as a general method to be used for the detection of exosomes for both clinical purposes and research. The challenges are both technical and biological and any step toward solving them is useful. The development of exosome detection methods is a continuous process and there is still a lot of room for improvement.

We used a synthetic peptide (Venceremin or Vn96), having a high affinity for canonical HSPs [24, 25] as tool to capture exosomes for the platform described in this work. The rational to use Vn96 based affinity-capture of exosomes for POC diagnostic platform is that cancer cells and their exosomes over express HSPs in their lumen as well as on their surface [26], but only at a minimum level in healthy cells or their exosomes. It is also evident that cancerous cells release a higher number of exosomes, compared to normal cells implicated in tumor progression [15, 27, 28]. Thus Vn96 provide stronger affinity capture of canonical HSP-overexpressed (from cancer cells) exosomes from a given body fluid on Vn96 grafted nanoplatforms and thus may provide superior diagnostic value for early cancer diagnosis [24].

While it is important to characterize exosomes by their molecular composition, there is presently a growing demand for an accurate method to detect the absolute concentration of exosomes in body fluids for potential POC diagnosis. For this purpose, surface-based detection methods such as Surface Plasmon Resonance (SPR) and, more recently, Localized Surface Plasmon Resonance (LSPR) have emerged, in addition to flow cytometry [29], Tunable Resistive Pulse Sensing (TRPS), and Nanoparticle Tracking Analysis (NTA).

LSPR is one of the most important optical properties of gold and silver nanostructures. It occurs, when the oscillation of free conduction electrons of nanoparticles is resonant with the incident light. Both the position and the intensity of LSPR band are dependent on the size and shape of nanoparticles and they are highly sensitive to dielectric properties of the surrounding medium.

Platforms based on gold nanoislands and silver nanoislands were used for numerous sensing applications [3036]. In this work, we have used a thermal convection method for the fabrication of nanoislands on glass substrates [33, 34]. We used a specific chemistry to covalently attach streptavidin to nanoislands, followed by grafting of the biotinylated Vn96 peptide to create a plasmonic surface where the exosomes will be captured.

The objective of the present study is to determine the detection capability of the Vn96-gold nanoislands platform by physical modeling. The density of Vn96- peptide molecules that can be accommodated on this platform has been evaluated and the concentrations of streptavidin, biotin-Vn96, and exosomes, have been estimated accordingly. At the same time, the different steps of the sensing protocol are discussed from the point of view of the successive binding events and their effect on the entire detection process. To the best of our knowledge, this is a new approach to evaluate the effectiveness of a nanoislands sensing platform, designed for the multistep, exosome capture, and detection. In an attempt to find new information that would be helpful for the exosome-based POC diagnosis, we tried to find a correlation between the experimental values of the Au-LSPR band shift and the amount of exosomes in the conditioned media of a breast cancer cell line. This modeling work is very useful in evaluating the morphology of new structures for a given size and concentration of exosomes or any other biomolecules.

2. Results and Discussions

2.1. SEM Characterization of Gold Nanoislands

The gold nano-islands on glass substrates, formed after annealing, were characterized by Scanning Electron Microscopy (SEM) and Transmission Electron Microscopy (TEM) images. Figures 1(a) and 1(b) show the SEM images of the gold aggregates, before annealing, and that of the nanoislands obtained after annealing, respectively. From the images, it can be seen that the annealing at 560°C for 1 hour, tunes the morphology from aggregates of gold nanoparticles into nanoislands. The TEM image shows that most of the islands have an ellipsoid shape and there is a wide size distribution.

2.2. Image Analysis of Gold Nanoislands

The SEM image of nanoislands is analyzed using the ImageJ analysis software (Wayne Rasband, NIH, USA) to determine the dimensions of the islands and their surface density. An area of 3.2 μm x 2.4 μm with 20 nanoislands is considered for the analysis. The nanoislands were analyzed, and the average length and width were measured and also the average interisland distances were calculated using the center to center distance between the nearest neighbor islands. The maximum and minimum lengths of nanoislands were found to be 450 nm and 60 nm and the widths 200 nm and 60 nm. Figures 1(c) and 1(d) show the image used for the analysis and Table 1 summarizes the average values of major and minor axes of gold nanoislands, aspect ratios, interisland distances and calculated surface density.

Length198.89 nm

Width146.67 nm

Aspect ratio1.37

Inter-island distance342.5 nm

Surface density3 nano-islands/μm2

Table 1 shows that the nanoislands are quite large, far from one to the other and their surface density is low. The size distribution of the gold nanoislands was also calculated. These calculations were based on the lower magnification SEM image shown in Fig. S1A. To calculate the island size distribution, an area of 12.7μm x 9.52μm is considered as shown in the rectangle in the Fig. S1B. The histogram in Fig. S1C clearly shows a wide size distribution (20 nm to approximately 350 nm diameter), all of the sizes having almost an equal contribution. The size distribution of nanoislands could be improved by annealing the deposited nanoparticles at the same temperature (560°C) but for a much longer time (10 h). The SEM image and the corresponding histogram are shown in Fig. S1 (D and F).

As the histogram shows, the sizes of the majority of islands are concentrated in the range of 20 nm to 80 nm. In spite of a better distribution, we opted for a shorter annealing time, because the size of nanoislands under these conditions is larger. Taking into account the complex multistep sensing protocol, having large nanoislands with a large penetration depth of the plasmon field would be more suitable and advantageous for higher sensitivity in the case of exosomes which are generally large in size.

2.3. Physical Modeling

In this section, we have built up a model based on the quantitative analysis of the nanoislands shown in the previous section. Taking into account the average size and the surface density of nanoislands as found from the SEM data, we have calculated the number of the different entities involved in the bio-sensing process that can be immobilized on the surface of nanoislands. When immobilizing the successive layers on the surface of a nanoisland, we have considered their dimensional sizes as known from the literature [37, 38]. A typical gold nanoisland has the shape of an ellipsoid as shown in Fig. S2A with average dimensions of 200 nm (L), 150 nm (W) and 50 nm (T) obtained from the particle analysis. The maximum area available for immobilization with these ellipsoidal nanoislands is approximated as

The surface area of nanoislands limits the number of different ligands that can be immobilized on its surface. The surface area calculated using (1) was used for further evaluations. Fig. S2B shows that, in spite of the larger size of the bio entities involved in the sensing process, the decaying plasmon field of a large nanoisland reaches the exosomes that are the target of the detection process. Fig. S2C shows the cross section of one nanoisland, carrying the successive layers of compounds involved in the detection of exosomes. As shown in the model (Fig. S2C), the ligands consist of a linker and the streptavidin bound to biotin-Vn96. The shape of the linker-streptavidin-biotin complex is assumed to be a rectangular body with the dimensions of 4.2 nm x 4.2 nm x 9 nm [37, 38]. The next layer consists of Vn96, a polypeptide specifically designed to capture exosomes, having a predictive spherical shape with a diameter of 2 nm and the exosomes are modeled as spheres with a diameter of 100 nm. Taking into account the available surface area, the numbers of Vn96 and exosomes that can be accommodated per nanoisland were estimated based on their physical dimensions and constraints and shown in Table 2.


Surface area of nano-island (A1)No. of ligandsSurface area for Vn96 (A3)No. of Vn96Surface area for exosomes (A4)No. of exosomes

3.486 x104 nm219764.49 x104 nm2128101.16 x105 nm29

It can be seen from the Table 2 that each nanoisland can accommodate a maximum of 1976 ligand of streptavidin, 12810 Vn96 molecules and only 9 exosomes. In our experiments, each Vn96 molecule is linked with a biotin through a PEG linker; therefore, the number of Vn96 a nanoisland can accommodate is equal to the number of biotin complexes, that is, 12810 on each nanoisland. As streptavidin can bind to 4 biotin molecules, while only 7904 biotin-PEG-Vn96 molecules can be bound to the maximum available streptavidin and the rest of the molecules will be washed away.

Theoretically, each Vn96 molecule can latch onto the exosome by binding to one heat shock protein contained on the surface of the exosomes. From the physical modeling, it is clear that the number of Vn96 molecules available to capture the exosomes is much higher than the exosomes that each nanoisland can accommodate. Hexagonal orientation of exosomes is considered, in order to understand how many Vn96 molecules could actually contribute to capture the exosomes. The percentage of Vn96 molecules involved in bonding of exosomes is very low, only around 5%. Fig. S2 (D and E) show the orientation of exosomes, while Fig. S2D shows the top view and Fig. S2E, the isometric view of the exosomes captured by the Vn96 molecules. The Vn96 molecules which actually contribute to the capture of exosomes are shown in orange as seen in Fig. S2 (D and E).

The biosensing protocol, tailored to detect the exosomes, consists of immobilization of different compounds on gold nanoislands, by binding or by adsorption of layers with varying thicknesses. For the approach used here, it is important to optimize the two step: the streptavidin-biotin binding and the capture of exosomes, while the concentrations of Nanothink and EDC-NHS used here are similar to those used for biosensing of other biomolecules [39]. For this purpose, the concentration and the amount of the entities involved in biosensing protocol were varied, to maximize the shift of the Au plasmon band, at each of the important steps. As the main step in deciding the outcome of the sensing process is the Vn96-exosome interaction, it seemed reasonable to optimize the formation of the streptavidin, biotin complex, in the specific case of biotin, connected to Vn96, through a PEG moiety. Because of the high affinity and the stability, the streptavidin-biotin model system and its structure and mechanism of formation have been thoroughly investigated [4042]. This is not the case for the biotin-PEG-Vn96 complex, synthesized quite recently, with the only objective of binding the exosomes.

First, only the concentration of streptavidin solution was varied to find the concentration that will result in the maximal shift of the Au LSPR band. The dependency of ∆λ on the concentrations of streptavidin is shown in Figure 2(a). The highest shift (4.5 nm) is seen when the concentration of streptavidin is around 0.04 nM. From the experimental results, it has been observed that, at lower concentrations of streptavidin, the LSPR shift values are unstable, compared to those corresponding to higher concentrations. Therefore, instead of considering concentrations with the highest LSPR shift, the concentration with a more stable LSPR shift is considered for further optimization of the biosensing protocol. The streptavidin concentration of 0.19 nM is considered and the concentration of Biotin-PEG-Vn96 is varied to study the effect of the ratio of Biotin-PEG-Vn96 to streptavidin. Figure 2(b) shows the dependency of the average LSPR shift when different ratios of biotin-PEG-Vn96 to streptavidin are used, keeping streptavidin concentration constant at 0.19 nM.

It is wellknown that one streptavidin molecule can bind to four biotin molecules and the LSPR shift corresponding to this ratio is maximal [40, 43]. Hence, if the ratio of streptavidin to biotin is maintained around four, the LSPR shift of Au has to be the largest. It is noticeable from Figure 2(b) that, as expected, the maximum shift is obtained when the ratio of biotin to streptavidin is maintained around four. This corresponds to 5.23 x1014 biotin-PEG-Vn96 complexes containing 1.14 x1014 molecules of streptavidin. Further, the LSPR shift decreases with the increase in ratio of the complex. The results have shown that, working with lower concentrations of biotin-PEG-Vn96 to streptavidin, the LSPR shift values show a poor repeatability. This might be because of less available biotin-PEG-Vn96 molecules, compared to those that may be accommodated by the streptavidin molecules and, in this situation, the binding is random. Comparing this number with the one calculated theoretically, it can be seen that, under the conditions of the experiment, a considerably higher number of complexes were formed. However, if we consider the removal of the nonbound complexes through the washing process, the number of molecules from the experimental results matches those from the physical modeling, validating the model.

The results show that the surface density of nanoislands, fabricated through the thermal convection method, is high enough to accommodate the biotin-PEG-Vn96 complex molecules, involved in the experiment. The optimized concentrations of all the entities used in the biosensing protocol and the corresponding LSPR shifts are summarized in table S1. The amount (volume) of each entity in the biosensing protocol is chosen to cover the whole sensing area.

The dependency curve, showing the shift of the Au LSPR band for different concentrations of exosomes, namely, corresponding to dilution factors of 50x, 25x, 10x, 5x, 1x is shown in Figure 2(c). Figure 2(d) represents the size distribution and counts of exosomes corresponding to different dilutions of MCF7 exosomes, quantified using the Tunable Resistive Pulse Sensing (TRPS) (qNano from iZON science) instrument. The dependency curve (Figure 2(c)) is built by using the concentration of MCF-7 exosomes, containing 1.33 X 1010 particles/ml. From this plot, it can be seen that the average shift increases as the dilution factor decreases and reaches the highest shift for the undiluted sample. It has to be noted that the equation of the curve reflects a nonlinear trend in the form of where x corresponds to the number of exosomes-Vn96 interactions. It can be observed from the experimental results that the LSPR shift has a nonlinear dependency on binding to the Vn96 and that the curve is not saturated, which clearly shows that the capacity of the nanoisland platform is still high enough to capture more exosomes than the actual number of exosomes in the culture media used in this experiment.

For modeling purposes, exosomes were considered spherical and having a uniform size (100 nm) but, actually, their size varies from 30 to 100 nm and the shape may not be exactly spherical as shown in Figure 2(e). An exosome, captured by a gold nanoisland is shown in Figure 2(f), whereas Figure 2(g) shows a cluster of exosomes, captured by a larger gold nanoisland as depicted in the modeling. This can be clearly seen in the in Fig. S3 (A and B). The number of available HSP on the surface of exosomes varies depending on the size of exosomes and the stage of the disease. When exosomes are captured by Vn96, the interactions could result in a deformation due their elastic nature. Hence, the binding of HSP to the Vn96 molecules (protein–protein binding) will result in a nonlinear behavior. The dependency curve allows the estimation of the concentration in terms of the number of exosomes in the sample.

Particle analysis has shown that the density of nanoislands is around 3 nanoislands/μm2. As found by modeling, each of them can accommodate 9 exosomes, that is, a total of 27 exosomes in an area of 1 μm2 of the developed platform. A previous study has indicated that the average number of exosomes that can be captured from a glioblastoma patient’s plasma on anti-CD63 monoclonal-antibody grafted 2D planner surface of the chip is 9 microvesicles/μm2 [15], whereas our platform is able to accommodate a much higher number of exosomes. As the sample used in this work corresponds to the cell culture of a breast cancer cell-line, the concentration of exosomes in the undiluted sample may be attributed to a cancerous condition as shown in Figure 3(c), where the total number of exosomes in the unit volume of plasma is noticeably higher than in the normal plasma [15]. Alternatively, the concentration of exosomes corresponding to a 50x dilution would mean a noncancerous situation or a very-early stage of the disease. Hence, the tested range of concentrations covers a wide range, starting with concentrations of exosome present in a given body-fluid, simulating a noncancerous, early-stage disease, to a fully developed cancerous condition. Thus, one can infer that the nanoisland platform developed in this work, based on LSPR, can effectively detect from early stage to advanced stages of cancer.

SEM and AFM images of exosomes from the breast cancer cells (MCF7) are shown in Figures 3(a) and 3(b) respectively. The relationship between the LSPR shift and the concentration of exosomes during cancer progression is schematically shown in Figure 3(c). It is known that the concentration of exosomes present in the body fluids increases tremendously (by many folds) in a cancer patient, compared to a healthy patient. For example, in the case of a glioblastoma patient’s plasma study mentioned above [15], the concentration of exosomes was found to be approximately 50 times higher than that corresponding to a healthy patient. Hence, we could envisage that the concentration of exosomes, detected by measuring the LSPR plasmonic shift, will reflect the progression of cancer as shown in Figure 3(c).

3. Conclusion

In this work, the sensing protocol for the LSPR detection of extracellular vesicles, based on their high affinity to the Vn96 polypeptide was optimized. A simple physical model was developed by analyzing the characteristics of gold nanoislands, calculating their surface area and the number of the different species that can be successively immobilized on the surface of a nanoisland. It is estimated that the most important step in the protocol, deciding the outcome of the overall sensing process, is the formation of the streptavidin-biotin-PEG-Vn96 complex. Therefore, the concentrations of streptavidin and biotin-PEG-Vn96 complex were optimized experimentally and the maximum LSPR shift was found for the ratio of 1 to 4 in agreement with the physical modeling. Particle analysis performed on SEM images has shown that the density of nanoislands is around 3 nanoislands/μm2. By modeling, it was found that each of the nanoislands can accommodate 9 exosomes, that is, a total of 27 exosomes per μm2. Practically, it means that the developed Au nanoisland platform can capture a much higher number of extracellular vesicles than that present in the MCF7 sample used for this study, providing a very broad detection range covering from early stages to advanced stages. Based on our preliminary results, the novel LSPR detection method of extracellular vesicles could be used as a tool to diagnose cancer at an early stage of the disease.

4. Materials and Methods

4.1. Materials

The substrates used in this experiment are the microscope glass slides purchased from Technologist Choice, Bio Nuclear diagnostics Inc., with a glass transition temperature, = 820°C. Substrates are cut to the size of 37 mm x 12.5mm x 1 mm. Gold (III) chloride trihydrate (HAuCl4.3H2O) and sodium citrate were purchased from Sigma Aldrich. De-ionized (DI) water with a resistivity of 18MΩ, used in all the experiments was obtained from the NANO pure ultrapure water system (Barnstead). 11-mercaptoundecanoic acid in ethanol (Nano Thinks Acid 11), N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) and N-Hydroxy succinimide (NHS), and phosphate buffered saline (PBS) was obtained from Sigma Aldrich, Canada. PBS tablets were dissolved in DI water at 0.1M concentration (pH = 7.2). Streptavidin was purchased from IBA GmBH. Biotin-PEG-Vn96 was purchased from New England Peptide. MCF7 exosomes were purified from MCF7 cells conditioned media in a bioreactor, using ultracentrifugation, and resuspended in fetal bovine serum free cell-culture media and the exosome concentration was determined by using NTA [24].

4.2. Fabrication of the Gold Nano-Island Platform

Three-dimensional (3D) gold (Au) nanoisland structures on glass substrates were fabricated from gold colloidal solution that, subsequently, was deposited on glass substrates by the thermal convection method. The gold colloidal solution was prepared by the reduction of Gold (III) Chloride trihydrate (HAuCl4.3H2O) (chloroauric acid) by sodium citrate, following Turkevich’s method [44]. Briefly, 15 mg of HAuCl4.3H2O was dissolved in 90 mL of DI water and heated until the solution reached its boiling point. Then, 5 mL of 2% sodium citrate solution is added to the boiling solution. After the addition of sodium citrate, a change in color from the original yellow to a transparent purple (wine red) can be clearly observed, showing the presence of gold nanoparticles. Meanwhile, the glass substrates were cleaned with soap solution and DI water, then rinsed with acetone, 2-propanol (IPA), and dried. Further, the substrates were heated at 100°C in an oven for 1 hour in order to remove the moisture and possible contaminants. The glass substrates were immersed in the beaker containing the gold colloidal solution at an angle of approximately 300 and kept at a temperature between 50 and 55°C. The Au nanoparticles from the colloidal suspension will slowly evaporate and deposit multilayers of Au particles on the substrate as shown in Fig. S4 (A and B). Au nanoislands were fabricated by annealing the samples at 560°C for one hour and 10 hours.

4.3. Biosensing Protocol

The different steps involved in the biosensing protocol and their corresponding LSPR shifts are shown in Fig. S5 (A and B). The first step consists of the functionalization of the Au nanoparticles by immersing the sample into the solution of 11-mercaptoundecanoic acid (Nanothink) (5mM) for 3 hours and then allowing it to dry. After this step, the absorption spectrum is measured using the Perkin Elmer spectrophotometer (Lambda650). The shift of the Au plasmon band towards longer wavelengths confirms the presence of the self-assembled monolayer of linker molecules on the surface of nano-islands. In the next step, the monolayer formed on the surface of Au nanoislands is activated by adding 200 μL of cross-linker, which is a mixture (1:1) of 0.1M N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) and 0.05M N-Hydroxysuccinimide (NHS), and then incubated for 2 hours. After drying, the spectrum is measured again. The next step is the immobilization of streptavidin to the activated linker layer. 200 μL of a 0.19 nM solution of streptavidin in water is added to the activated linker layer and incubated for an hour and left to dry before taking a spectral measurement. In the next step, 200 μL of a 0.87 nM of biotin-PEG-Vn96 solution is deposited on top of the streptavidin layer and incubated for 4 hours and dried and the spectral measurement is taken again. The final step of the biosensing protocol includes in the deposition of 200 μL of the MCF 7 (breast cancer cell line) cell culture conditioned media, containing EVs/exosomes for their relative immobilization.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this article.

Authors’ Contributions

S.B. (Simona Badilescu), M. Packirisamy, and A. Ghosh conceived the study and experiments. S.B. (Srinivas Bathini), D. Raju, and A. Kumar carried out experiments and contributed to the manuscript. R. J. Ouellette provided the materials. All authors reviewed the manuscript.


The authors acknowledge the support of M. Packirisamy from Natural Sciences and Engineering Research Council of Canada (NSERC) and Concordia Research Chair and New Brunswick Innovation Foundation (NBIF).

Supplementary Materials

Fig.S1: Size distributions of gold nanoislands under two different annealing times. (A) Large area SEM image of gold nanoislands after 1-hour annealing; (B) binary image of 1-hour annealed gold nanoislands; (C) histogram corresponding to size distribution of 1-hour annealed gold nanoislands; (D) SEM image of gold nanoislands after 10 hours of annealing; (E) binary image of 10 hours annealed gold nanoislands; (F) histogram corresponding to size distribution of 10 hours annealed gold nanoislands. Fig.S2: Physical modeling of interactions. (A) Gold nanoisland in the shape of a half-ellipsoid (B) decay of the plasmon field of a large nanoisland. (C) Cross section of one nanoisland immobilized with the successive layers of bioentities involved in the detection of exosomes. Exosomes captured by Vn96 molecules ((D) top view and (E) isometric view). The spheres in pink and blue represent the exosomes and the Vn96 molecules, respectively. Fig.S3: SEM image of gold nanoislands with and without exosomes. (A) SEM image of the gold nanoislands without exosomes. (B) SEM image of the gold nanoislands with exosomes. Fig.S4: Fabrication of gold nanoisland platforms. (A) Schematic of the convective assembly process. (B) Schematic of the morphological tuning of gold multilayers to gold islands by annealing. Fig.S5: Biosensing protocol and their corresponding absorbance bands. (A) Schematic of the biosensing protocol. (B) Au nanoisland plasmon band corresponding to the different steps of the protocol. Table S1: Concentrations and volume of the entities used in the biosensing protocol with their corresponding average LSPR shift. (Supplementary Materials)


  1. G. Fuhrmann, I. K. Herrmann, and M. M. Stevens, “Cell-derived vesicles for drug therapy and diagnostics: Opportunities and challenges,” Nano Today, vol. 10, no. 3, pp. 397–409, 2015. View at: Publisher Site | Google Scholar
  2. M. Yáñez-Mó, P. R.-M. Siljander, Z. Andreu et al., “Biological properties of extracellular vesicles and their physiological functions,” Journal of Extracellular Vesicles (JEV), vol. 4, no. 2015, pp. 1–60, 2015. View at: Google Scholar
  3. B. György, T. G. Szabó, M. Pásztói et al., “Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles,” Cellular and Molecular Life Sciences, vol. 68, no. 16, pp. 2667–2688, 2011. View at: Publisher Site | Google Scholar
  4. J. Conde-Vancells, E. Rodriguez-Suarez, N. Embade et al., “Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes,” Journal of Proteome Research, vol. 7, no. 12, pp. 5157–5166, 2008. View at: Publisher Site | Google Scholar
  5. E. van der Pol, A. N. Böing, P. Harrison, A. Sturk, and R. Nieuwland, “Classification, functions, and clinical relevance of extracellular vesicles,” Pharmacological Reviews, vol. 64, no. 3, pp. 676–705, 2012. View at: Publisher Site | Google Scholar
  6. J. Kowal, G. Arras, M. Colombo et al., “Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 113, no. 8, pp. E968–E977, 2016. View at: Publisher Site | Google Scholar
  7. A. de Maio, “Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: a form of communication during injury, infection, and cell damage: It is never known how far a controversial finding will go! Dedicated to Ferruccio Ritossa,” Cell Stress and Chaperones, vol. 16, no. 3, pp. 235–249, 2011. View at: Publisher Site | Google Scholar
  8. V. L. Vega, M. Rodríguez-Silva, T. Frey et al., “Hsp70 translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages,” The Journal of Immunology, vol. 180, no. 6, pp. 4299–4307, 2008. View at: Publisher Site | Google Scholar
  9. G. I. Lancaster and M. A. Febbraio, “Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins,” The Journal of Biological Chemistry, vol. 280, no. 24, pp. 23349–23355, 2005. View at: Publisher Site | Google Scholar
  10. R. Gastpar, M. Gehrmann, M. A. Bausero et al., “Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells,” Cancer Research, vol. 65, no. 12, pp. 5238–5247, 2005. View at: Publisher Site | Google Scholar
  11. C. Campanella, F. Bucchieri, A. M. Merendino et al., “The odyssey of Hsp60 from tumor cells to other destinations includes plasma membrane-associated stages and Golgi and exosomal protein-trafficking modalities,” PLoS ONE, vol. 7, no. 7, 2012. View at: Google Scholar
  12. J. S. Schorey and S. Bhatnagar, “Exosome function: from tumor immunology to pathogen biology,” Traffic, vol. 9, no. 6, pp. 871–881, 2008. View at: Publisher Site | Google Scholar
  13. C. Théry, M. Ostrowski, and E. Segura, “Membrane vesicles as conveyors of immune responses,” Nature Reviews Immunology, vol. 9, no. 8, pp. 581–593, 2009. View at: Publisher Site | Google Scholar
  14. C. Campanella, C. C. Bavisotto, A. Marino Gammazza et al., “Exosomal heat shock proteins as new players in tumour cell-to-cell communication,” Journal of Circulating Biomarkers, vol. 3, 2014. View at: Google Scholar
  15. C. Chen, J. Skog, C.-H. Hsu et al., “Microfluidic isolation and transcriptome analysis of serum microvesicles,” Lab on a Chip, vol. 10, no. 4, pp. 505–511, 2010. View at: Publisher Site | Google Scholar
  16. S. S. Kanwar, C. J. Dunlay, D. M. Simeone, and S. Nagrath, “Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes,” Lab on a Chip, vol. 14, no. 11, pp. 1891–1900, 2014. View at: Publisher Site | Google Scholar
  17. Z. Zhao, Y. Yang, Y. Zeng, and M. He, “A microfluidic ExoSearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis,” Lab on a Chip, vol. 16, no. 3, pp. 489–496, 2016. View at: Publisher Site | Google Scholar
  18. M. He, J. Crow, M. Roth, Y. Zeng, and A. K. Godwin, “Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology,” Lab on a Chip, vol. 14, no. 19, pp. 3773–3780, 2014. View at: Publisher Site | Google Scholar
  19. S. Jeong, J. Park, D. Pathania, C. M. Castro, R. Weissleder, and H. Lee, “Integrated magneto-electrochemical sensor for exosome analysis,” ACS Nano, vol. 10, no. 2, pp. 1802–1809, 2016. View at: Publisher Site | Google Scholar
  20. S. Yadav, K. Boriachek, M. N. Islam et al., “An electrochemical method for the detection of disease-specific exosomes,” ChemElectroChem, vol. 4, no. 4, pp. 967–971, 2017. View at: Publisher Site | Google Scholar
  21. X. Doldán, P. Fagúndez, A. Cayota, J. Laíz, and J. P. Tosar, “Electrochemical sandwich immunosensor for determination of exosomes based on surface marker-mediated signal amplification,” Analytical Chemistry, vol. 88, no. 21, pp. 10466–10473, 2016. View at: Publisher Site | Google Scholar
  22. Y.-G. Zhou, R. M. Mohamadi, M. Poudineh et al., “Interrogating circulating microsomes and exosomes using metal nanoparticles,” Small, vol. 12, no. 6, pp. 727–732, 2016. View at: Publisher Site | Google Scholar
  23. K. Boriachek, M. N. Islam, A. Möller et al., “Biological functions and current advances in isolation and detection strategies for exosome nanovesicles,” Small, vol. 14, no. 6, 2018. View at: Google Scholar
  24. A. Ghosh, M. Davey, I. C. Chute et al., “Rapid isolation of extracellular vesicles from cell culture and biological fluids using a synthetic peptide with specific affinity for heat shock proteins,” PLoS ONE, vol. 9, no. 10, Article ID e110443, 2014. View at: Publisher Site | Google Scholar
  25. S. G. Griffiths, M. T. Cormier, A. Clayton, and A. A. Doucette, “Differential proteome analysis of extracellular vesicles from breast cancer cell lines by chaperone affinity enrichment,” Proteomes, vol. 5, no. 4, 2017. View at: Google Scholar
  26. J. Gobbo, G. Marcion, M. Cordonnier et al., “Restoring anticancer immune response by targeting tumor-derived exosomes with a HSP70 peptide aptamer,” Journal of the National Cancer Institute, vol. 108, article djv330, no. 3, 2016. View at: Publisher Site | Google Scholar
  27. X. Zhang, X. Yuan, H. Shi, L. Wu, H. Qian, and W. Xu, “Exosomes in cancer: Small particle, big player,” Journal of Hematology & Oncology, vol. 8, no. 1, article no. 83, 2015. View at: Publisher Site | Google Scholar
  28. M. He and Y. Zeng, “Microfluidic exosome analysis toward liquid biopsy for cancer,” Journal of Laboratory Automation, vol. 21, no. 4, pp. 599–608, 2016. View at: Publisher Site | Google Scholar
  29. E. N. Nolte-'t Hoen, E. J. van der Vlist, M. Aalberts et al., “Quantitative and qualitative flow cytometric analysis of nanosized cell-derived membrane vesicles,” Nanomedicine: Nanotechnology, Biology and Medicine, vol. 8, no. 5, pp. 712–720, 2012. View at: Publisher Site | Google Scholar
  30. S. Unser, I. Bruzas, J. He, and L. Sagle, “Localized surface plasmon resonance biosensing: Current challenges and approaches,” Sensors, vol. 15, no. 7, pp. 15684–15716, 2015. View at: Publisher Site | Google Scholar
  31. J. Algorri, D. Poudereux, B. García-Cámara et al., “Metal nanoparticles-PDMS nanocomposites for tunable optical filters and sensors,” Optical Data Processing and Storage, vol. 2, no. 1, 2016. View at: Publisher Site | Google Scholar
  32. P. Singh, “LSPR Biosensing: Recent Advances and Approaches,” in Reviews in Plasmonics 2016, vol. 2016 of Reviews in Plasmonics, pp. 211–238, Springer International Publishing, Cham, 2017. View at: Publisher Site | Google Scholar
  33. J. Ozhikandathil and M. Packirisamy, “Simulation and implementation of a morphology-tuned gold nano-islands integrated plasmonic sensor,” Sensors, vol. 14, no. 6, pp. 10497–10513, 2014. View at: Publisher Site | Google Scholar
  34. M. Fanous, S. Badilescu, and M. Packirisamy, “Thermal manipulation of gold nanocomposites for microfluidic platform optimization,” Plasmonics, vol. 13, no. 1, pp. 305–313, 2018. View at: Publisher Site | Google Scholar
  35. H. SadAbadi, S. Badilescu, M. Packirisamy, and R. Wüthrich, “Integration of gold nanoparticles in PDMS microfluidics for lab-on-a-chip plasmonic biosensing of growth hormones,” Biosensors and Bioelectronics, vol. 44, no. 1, pp. 77–84, 2013. View at: Publisher Site | Google Scholar
  36. D. Raju, S. Bathini, S. Badilescu, R. J. Ouellette, A. Ghosh, and M. Packirisamy, “Exosomes detection by a label-free localized surface plasmonic resonance method,” ECS Trans, vol. 75, pp. 11–17, 2016. View at: Google Scholar
  37. H. Hinterwirth, S. Kappel, T. Waitz, T. Prohaska, W. Lindner, and M. Lämmerhofer, “Quantifying thiol ligand density of self-assembled monolayers on gold nanoparticles by inductively coupled plasma-mass spectrometry,” ACS Nano, vol. 7, no. 2, pp. 1129–1136, 2013. View at: Publisher Site | Google Scholar
  38. Y. Li and H. Zhang, “Binding of streptavidin to surface-attached biotin with different spacer thicknesses,” Journal of Wuhan University of Technology-Mater. Sci. Ed., vol. 30, no. 6, pp. 1304–1309, 2015. View at: Publisher Site | Google Scholar
  39. J. Ozhikandathil, S. Badilescu, and M. Packirisamy, “Gold nanoisland structures integrated in a lab-on-a-chip for plasmonic detection of bovine growth hormone,” Journal of Biomedical Optics, vol. 17, no. 7, Article ID 077001, 2012. View at: Publisher Site | Google Scholar
  40. P. C. Weber, D. H. Ohlendorf, J. J. Wendoloski, and F. R. Salemme, “Structural origins of high-affinity biotin binding to streptavidin,” Science, vol. 243, no. 4887, pp. 85–88, 1989. View at: Publisher Site | Google Scholar
  41. P. C. Weber, J. J. Wendoloski, M. W. Pantoliano, and F. R. Salemme, “Crystallographic and thermodynamic comparison of natural and synthetic ligands bound to streptavidin,” Journal of the American Chemical Society, vol. 114, no. 9, pp. 3197–3200, 1992. View at: Publisher Site | Google Scholar
  42. M. Lösche, C. Erdelen, E. Rump, H. Ringsdorf, K. Kjaer, and D. Vaknin, “On the lipid head group hydration of floating surface monolayers bound to self-assembled molecular protein layers,” Thin Solid Films, vol. 242, no. 1-2, pp. 112–117, 1994. View at: Publisher Site | Google Scholar
  43. E. P. Diamandis and T. K. Christopoulos, “The biotin-(strept)avidin system: Principles and applications in biotechnology,” Clinical Chemistry, vol. 37, no. 5, pp. 625–636, 1991. View at: Google Scholar
  44. J. Turkevich, P. C. Stevenson, and J. Hillier, “A study of the nucleation and growth processes in the synthesis of colloidal gold,” Discussions of the Faraday Society, vol. 11, pp. 55–75, 1951. View at: Publisher Site | Google Scholar

Copyright © 2018 S. Bathini et al. Exclusive licensee Science and Technology Review Publishing House. Distributed under a Creative Commons Attribution License (CC BY 4.0).

2945 Views | 649 Downloads | 4 Citations
 PDF Download Citation Citation

Altmetric Attention Score

Find out more
 Sign up for content alerts